{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:42:59Z","timestamp":1792100579363,"version":"4.4.0"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,12]]},"DOI":"10.18632\/oncotarget.11851","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T07:06:44Z","timestamp":1473145604000},"page":"68571-68584","source":"Crossref","is-referenced-by-count":70,"title":["Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model"],"prefix":"10.18632","volume":"7","author":[{"given":"Tara","family":"Williamson","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Yuan","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Staedtke","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Huso","sequence":"additional","affiliation":[{"name":"Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Riggins","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal cancer","volume":"348","author":"de la Chapelle","year":"2003","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","article-title":"Lessons from hereditary colorectal cancer","volume":"87","author":"Vogelstein","year":"1996","journal-title":"Cell"},{"key":"3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1897-4287-1-1-19","article-title":"Familial Adenomatous Polyposis (FAP) and Other Polyposis Syndromes","volume":"1","author":"Scott","year":"2003","journal-title":"Hereditary Cancer in Clinical Practice"},{"key":"4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1350108","article-title":"Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene","volume":"256","author":"Dove","year":"1992","journal-title":"Science"},{"key":"5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/359235a0","article-title":"APC mutations occur early during colorectal tumorigenesis","volume":"359","author":"Kinzler","year":"1992","journal-title":"Nature"},{"key":"6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","article-title":"Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC","volume":"275","author":"Kinzler","year":"1997","journal-title":"Science"},{"key":"7","first-page":"19","article-title":"Genetic alterations in colorectal cancer","volume":"5","author":"Mills","year":"2012","journal-title":"Gastrointest Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway","volume":"281","author":"Kinzler","year":"1998","journal-title":"Science"},{"key":"9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/18884","article-title":"Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells","volume":"398","author":"McCormick","year":"1999","journal-title":"Nature"},{"key":"10","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","article-title":"Inflammation and colon cancer","volume":"138","author":"Karin","year":"2010","journal-title":"Gastroenterology"},{"key":"11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","article-title":"The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment","volume":"30","author":"Kaidi","year":"2009","journal-title":"Carcinogenesis"},{"key":"12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cyto.2011.09.027","article-title":"Intestinal inflammatory cytokine response in relation to tumorigenesis in the Apc(Min\/+) mouse","volume":"57","author":"Murphy","year":"2012","journal-title":"Cytokine"},{"key":"13","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1053\/j.gastro.2015.07.064","article-title":"Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice","volume":"149","author":"DuBois","year":"2015","journal-title":"Gastroenterology"},{"key":"14","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular origins of cancer: Molecular basis of colorectal cancer","volume":"361","author":"Bertagnolli","year":"2009","journal-title":"N Engl J Med"},{"key":"15","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/1078-0432.CCR-06-2416","article-title":"Vascular endothelial growth factor and its relationship to inflammatory mediators","volume":"13","author":"Kurzrock","year":"2007","journal-title":"Clin Cancer Res"},{"key":"16","first-page":"181","article-title":"COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs","volume":"3","author":"Piazza","year":"2013","journal-title":"Front Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues","volume":"94","author":"Patrono","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/carcin\/17.8.1757","article-title":"Sulindac suppresses tumorigenesis in the Min mouse","volume":"17","author":"Kinzler","year":"1996","journal-title":"Carcinogenesis"},{"key":"19","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMoa012015","article-title":"Primary chemoprevention of familial adenomatous polyposis with sulindac","volume":"346","author":"Hamilton","year":"2002","journal-title":"N Engl J Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/CEJ.0b013e32834dbbfd","article-title":"Combination chemoprevention: future direction of colorectal cancer prevention","volume":"21","author":"Liu","year":"2012","journal-title":"Eur J Cancer Prev"},{"key":"21","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00432-013-1539-5","article-title":"Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer","volume":"139","author":"Larsson","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/0284186X.2013.844359","article-title":"Drug repositioning from bench to bedside: tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer","volume":"53","author":"Larsson","year":"2014","journal-title":"Acta Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/neuonc\/nor077","article-title":"Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme","volume":"13","author":"Riggins","year":"2011","journal-title":"Neuro Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/neuonc\/nou234","article-title":"Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis","volume":"17","author":"Riggins","year":"2015","journal-title":"Neuro Oncol"},{"key":"25","first-page":"2038","article-title":"The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model","volume":"29","author":"Montenegro","year":"2015","journal-title":"Toxicology"},{"key":"26","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-07-2159","article-title":"Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells","volume":"6","author":"Orlow","year":"2008","journal-title":"Mol Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00280-007-0538-0","article-title":"Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice","volume":"61","author":"Mazzoni","year":"2008","journal-title":"Cancer chemotherapy and pharmacology"},{"key":"28","first-page":"1201","article-title":"The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells","volume":"1","author":"Mukhopadhyay","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"29","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.4158\/EP10390.CR","article-title":"Mebendazole monotherapy and long-term disease control in metastatic adrenocortical carcinoma","volume":"17","author":"Worden","year":"2011","journal-title":"Endocrine practice"},{"key":"30","first-page":"391","article-title":"Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system","volume":"12","author":"Pierre","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"31","first-page":"2556","article-title":"Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis","volume":"56","author":"Bertagnolli","year":"1996","journal-title":"Cancer Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/carcin\/24.3.605","article-title":"Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations","volume":"24","author":"Lipkin","year":"2003","journal-title":"Carcinogenesis"},{"key":"33","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/carcin\/bgl113","article-title":"Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin\/+ mouse model of early intestinal cancer","volume":"27","author":"Wilkinson","year":"2006","journal-title":"Carcinogenesis"},{"key":"34","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1158\/1541-7786.MCR-07-0232","article-title":"Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin\/+ mice due to decreases in c-Myc expression","volume":"5","author":"Baudino","year":"2007","journal-title":"Mol Cancer Res"},{"key":"35","first-page":"2963","article-title":"Mebendazole elicits a potent antitumor effect on human cancer cell lines bothand","volume":"8","author":"Roth","year":"2002","journal-title":"Clin Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/bst0150059","article-title":"Microtubules as target organelles for benzimidazole anthelmintic chemotherapy","volume":"15","author":"Byard","year":"1987","journal-title":"Biochem Soc Trans"},{"key":"37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0006-291X(80)90349-6","article-title":"Inhibition of tubulin polymerization by mebendazole","volume":"92","author":"Zetina","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"38","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/adc.66.4.532","article-title":"High mebendazole doses in pulmonary and hepatic hydatid disease","volume":"66","author":"Matsaniotis","year":"1991","journal-title":"Archives of disease in childhood"},{"key":"39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1053\/gast.2002.31890","article-title":"Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study","volume":"122","author":"Giardiello","year":"2002","journal-title":"Gastroenterology"},{"key":"40","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-14-2681","article-title":"Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model","volume":"21","author":"Riggins","year":"2015","journal-title":"Clin Cancer Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1158\/0008-5472.CAN-05-1949","article-title":"Inhibition of intestinal tumorigenesis in Apcmin\/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1258\/002367781780958577","article-title":"The \u201cSwiss roll\u201d: a simple technique for histological studies of the rodent intestine","volume":"15","author":"Ruitenberg","year":"1981","journal-title":"Lab Anim"},{"key":"43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00666038","article-title":"Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors","volume":"36","author":"Weidner","year":"1995","journal-title":"Breast Cancer Res Treat"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T09:31:41Z","timestamp":1589275901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":43,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2016,10,12]]}},"alternative-id":["11851","27612418"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11851","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]}}}